{"schema_version":"secwatch.filing_event.v1","accession":"0001779128-23-000075","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.196011+00:00","generated_at":"2026-06-11T22:57:57.953828+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Blade Q2 revenue $61M (+71%), medical $34.4M (+99%), net loss $12.2M","bullets":["Q2 revenue $61.0M (+71% YoY); medical revenue $34.4M (+99% YoY, +29% sequentially).","Flight Profit $10.4M (+103% YoY); Flight Margin 17.0% vs 14.3%.","GAAP net loss $12.2M vs net income $8.4M in prior-year quarter.","Adjusted EBITDA -$4.4M vs -$6.1M, improved 27%; Medical Adj. EBITDA $3.0M.","Short Distance revenue up 75% YoY, driven by Blade Europe acquisition and organic growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001779128-23-000075","json":"https://secwatch.observer/filing/0001779128-23-000075.json","markdown":"https://secwatch.observer/filing/0001779128-23-000075.md","text":"https://secwatch.observer/filing/0001779128-23-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000177912823000075/0001779128-23-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000177912823000075/blde-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T22:57:57.953828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42f3098c496e38a684001f14deaac872a7641097","claim":"Strata Critical Medical, Inc. reported second quarter ended June 30, 2023 results: revenue $61.0 million, net income $(12,232).","evidence_excerpt":"9, 2023 Blade Air Mobility Reports Financial Results for the Second Quarter Ended June 30, 2023 • Second quarter ended June 30, 2023 revenue up 71% versus the prior year to $61.0 million • Medical revenue of $34.4 million in Q2 2023 up 99% versus the prior year period, up 29% sequentially versus Q1 2023 • Short Distance revenue up 75% in Q2 2023 versus the prior","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912823000075/0001779128-23-000075-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$61.0 million"},{"label":"Net income","value":"$(12,232)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}